ArticleUnited European gastroenterology journal2017

The majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug-drug interactions.

Elise J Smolders et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.